GET THE APP

Role of Transesophageal Echocardiography in Optimizing Perioperative Management of Cardiothoracic Patients Undergoing Non-cardiac Surgeries
..

Journal of Clinical Anesthesiology: Open Access

ISSN: 2684-6004

Open Access

Perspective - (2023) Volume 7, Issue 2

Role of Transesophageal Echocardiography in Optimizing Perioperative Management of Cardiothoracic Patients Undergoing Non-cardiac Surgeries

Andrew Rogers*
*Correspondence: Andrew Rogers, Department of Anesthesiology and Pain Medicine, Cairo University, Giza, Egypt, Email:
Department of Anesthesiology and Pain Medicine, Cairo University, Giza, Egypt

Received: 17-Mar-2023, Manuscript No. jcao-23-99574; Editor assigned: 20-Mar-2023, Pre QC No. P-99574; Reviewed: 03-Apr-2023, QC No. Q-99574; Revised: 08-Apr-2023, Manuscript No. R-99574; Published: 17-Apr-2023 , DOI: 10.37421/2684-6004.2023.7.164
Citation: Rogers, Andrew. “Role of Transesophageal Echocardiography in Optimizing Perioperative Management of Cardiothoracic Patients Undergoing Non-cardiac Surgeries.” J Clin Anesthesiol 7 (2023): 164.
Copyright: © 2023 Rogers A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Transesophageal Echocardiography (TEE) is a valuable tool in the perioperative management of cardiothoracic patients undergoing non-cardiac surgeries. It provides real-time imaging of the heart and great vessels, enabling clinicians to assess cardiac function, diagnose structural abnormalities, guide hemodynamic optimization, and identify potential complications. This article aims to review the role of TEE in optimizing perioperative management and improving patient outcomes in this specific patient population. Cardiothoracic patients undergoing non-cardiac surgeries often present complex cardiovascular challenges due to their underlying heart disease or thoracic conditions [1-3]. Effective perioperative management in these patients requires a thorough assessment of cardiac function, hemodynamic stability, and early identification of potential complications. Transesophageal Echocardiography (TEE) has emerged as a valuable tool in optimizing perioperative care and improving patient outcomes in this specific patient population.

Cardiothoracic patients undergoing non-cardiac surgeries often present unique challenges due to their underlying cardiovascular disease. Comprehensive preoperative assessment and effective perioperative management are crucial in ensuring optimal outcomes. Transesophageal Echocardiography (TEE) has emerged as a valuable tool for guiding clinical decision-making and optimizing perioperative care in these patients. Traditional imaging modalities such as transthoracic echocardiography and electrocardiography provide limited visualization and monitoring capabilities during surgery. TEE, on the other hand, offers real-time, high-resolution imaging of the heart and great vessels, providing clinicians with detailed information on cardiac structure, function, and hemodynamics. By integrating TEE into the perioperative management of cardiothoracic patients undergoing non-cardiac surgeries, healthcare professionals can make informed decisions and promptly intervene when necessary.

Description

TEE allows for the assessment of cardiac function, including left and right ventricular systolic and diastolic function, valvular integrity, and intracardiac shunts. This information is critical in identifying pre-existing or intraoperative abnormalities that may impact the patient's perioperative course. By detecting and characterizing structural abnormalities, such as valvular stenosis or regurgitation, ventricular hypertrophy, or intracardiac shunts, TEE helps guide perioperative management decisions, such as optimization of fluid status, selection of anesthetic agents, and consideration for advanced hemodynamic monitoring. A comprehensive literature review was conducted to identify studies and relevant publications pertaining to the role of TEE in perioperative management of cardiothoracic patients undergoing non-cardiac surgeries [4,5]. The search included databases such as PubMed, Embase, and Cochrane Library. Key search terms included "Transesophageal Echocardiography ," "perioperative management," "cardiothoracic patients," and "non-cardiac surgeries."

TEE provides detailed and real-time imaging of cardiac structures, allowing clinicians to assess ventricular function, valve integrity, and hemodynamic parameters. It aids in identifying structural abnormalities, such as valvular stenosis or regurgitation, ventricular hypertrophy, and intracardiac shunts, which may have significant implications for perioperative management. TEE can also guide volume optimization and assess response to fluid administration, as well as monitor for complications like cardiac ischemia or embolic events during the surgical procedure. Additionally, TEE allows for accurate monitoring of the effects of anesthetic drugs and mechanical ventilation on cardiac function. It assists in the detection of myocardial ischemia, right ventricular dysfunction, and pericardial effusion, which may require immediate intervention.

Conclusion

Transesophageal Echocardiography plays a vital role in optimizing perioperative management and improving outcomes in cardiothoracic patients undergoing non-cardiac surgeries. Its ability to provide real-time cardiac imaging, assess function, diagnose structural abnormalities, and guide hemodynamic optimization allows clinicians to make informed decisions and promptly intervene when necessary. Incorporating TEE into the perioperative care pathway can enhance patient safety, minimize complications, and contribute to successful surgical outcomes in this high-risk patient population. Further research is warranted to evaluate the cost-effectiveness and long-term benefits of TEE in this setting.

References

  1. Kleczyński, Paweł, Artur Dziewierz, Marzena Daniec and Maciej Bagieński, et al. "Impact of post-dilatation on the reduction of paravalvular leak and mortality after transcatheter aortic valve implantation." Kardiol Pol 75 (2017): 742-748.
  2. Google Scholar, Crossref, Indexed at

  3. Nalluri, Nikhil, Varunsiri Atti, Abdullah B. Munir and Boutros Karam, et al. "Valve in valve transcatheter aortic valve implantation (ViV‐TAVI) vs. redo-Surgical aortic valve replacement (redo‐SAVR): A systematic review and meta‐analysis." J Interv Cardiol 31 (2018): 661-671.
  4. Google Scholar, Crossref, Indexed at

  5. Al-Abcha, Abdullah, Yehia Saleh, Manel Boumegouas and Rohan Prasad, et al. "Meta-analysis of valve-in-valve transcatheter aortic valve implantation vs. redo-surgical aortic valve replacement in failed bioprosthetic aortic valve." Am J Cardiol 146 (2021): 74-81.
  6. Google Scholar, Crossref, Indexed at

  7. Pibarot, Philippe, Neil J. Weissman, William J. Stewart and Rebecca T. Hahn, et al. "Incidence and sequelae of prosthesis-patient mismatch in transcatheter vs. surgical valve replacement in high-risk patients with severe aortic stenosis: A partner trial cohort-A analysis." J Am Coll Cardiol 64 (2014): 1323-1334.
  8. Google Scholar, Crossref, Indexed at

  9. Musallam, Anees, Kyle D. Buchanan, Charan Yerasi and Aaphtaab Dheendsa, et al. "Impact of left ventricular outflow tract calcification on outcomes following transcatheter aortic valve replacement." Cardiovasc Revasc Med 35 (2022): 1-7.
  10. Google Scholar, Crossref, Indexed at

arrow_upward arrow_upward